125 related articles for article (PubMed ID: 7923093)
1. Characterization of bombesin/gastrin-releasing peptide receptors in membranes of MKN45 human gastric cancer.
Halmos G; Pinski J; Szoke B; Schally AV
Cancer Lett; 1994 Sep; 85(1):111-8. PubMed ID: 7923093
[TBL] [Abstract][Full Text] [Related]
2. Bombesin antagonists inhibit in vitro and in vivo growth of human gastric cancer and binding of bombesin to its receptors.
Qin Y; Halmos G; Cai RZ; Szoke B; Ertl T; Schally AV
J Cancer Res Clin Oncol; 1994; 120(9):519-28. PubMed ID: 8045917
[TBL] [Abstract][Full Text] [Related]
3. Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression.
Halmos G; Wittliff JL; Schally AV
Cancer Res; 1995 Jan; 55(2):280-7. PubMed ID: 7812958
[TBL] [Abstract][Full Text] [Related]
4. Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells.
Reile H; Armatis PE; Schally AV
Prostate; 1994 Jul; 25(1):29-38. PubMed ID: 8022709
[TBL] [Abstract][Full Text] [Related]
5. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.
Halmos G; Schally AV
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):956-60. PubMed ID: 9023364
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160.
Pinski J; Halmos G; Yano T; Szepeshazi K; Qin Y; Ertl T; Schally AV
Int J Cancer; 1994 May; 57(4):574-80. PubMed ID: 7910153
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a bombesin/gastrin-releasing peptide receptor on a human gastric-cancer cell line.
Preston SR; Woodhouse LF; Gokhale J; Miller GV; Primrose JN
Int J Cancer; 1994 Jun; 57(5):734-41. PubMed ID: 8194883
[TBL] [Abstract][Full Text] [Related]
8. Bombesin receptors in a human duodenal tumor cell line: binding properties and function.
Williams BY; Schonbrunn A
Cancer Res; 1994 Feb; 54(3):818-24. PubMed ID: 8306345
[TBL] [Abstract][Full Text] [Related]
9. High affinity binding sites for gastrin releasing peptide on human gastric cancer and Ménétrier's mucosa.
Preston SR; Woodhouse LF; Jones-Blackett S; Wyatt JI; Primrose JN
Cancer Res; 1993 Nov; 53(21):5090-2. PubMed ID: 8221641
[TBL] [Abstract][Full Text] [Related]
10. The binding of bombesin and somatostatin and their analogs to human colon cancers.
Radulovic SS; Milovanovic SR; Cai RZ; Schally AV
Proc Soc Exp Biol Med; 1992 Jul; 200(3):394-401. PubMed ID: 1352046
[TBL] [Abstract][Full Text] [Related]
11. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
[TBL] [Abstract][Full Text] [Related]
12. Interaction of [125I]-Tyr4-bombesin with specific receptors on normal human pancreatic membranes.
Scemama JL; Zahidi A; Fourmy D; Fagot-Revurat P; Vaysse N; Pradayrol L; Ribet A
Regul Pept; 1986 Jan; 13(2):125-32. PubMed ID: 3006155
[TBL] [Abstract][Full Text] [Related]
13. High-affinity binding sites for gastrin-releasing peptide on human colorectal cancer tissue but not uninvolved mucosa.
Preston SR; Woodhouse LF; Jones-Blackett S; Miller GV; Primrose JN
Br J Cancer; 1995 May; 71(5):1087-9. PubMed ID: 7734305
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the high-affinity receptors on Swiss 3T3 cells which mediate the binding, internalization and degradation of the mitogenic peptide bombesin.
Brown KD; Laurie MS; Littlewood CJ; Blakeley DM; Corps AN
Biochem J; 1988 May; 252(1):227-35. PubMed ID: 2844145
[TBL] [Abstract][Full Text] [Related]
15. Bombesin receptor in membranes from Swiss 3T3 cells. Binding characteristics, affinity labelling and modulation by guanine nucleotides.
Sinnett-Smith J; Lehmann W; Rozengurt E
Biochem J; 1990 Jan; 265(2):485-93. PubMed ID: 2154190
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of growth of MDA-MB-468 estrogen-independent human breast carcinoma by bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II.
Kahán Z; Sun B; Schally AV; Arencibia JM; Cai RZ; Groot K; Halmos G
Cancer; 2000 Mar; 88(6):1384-92. PubMed ID: 10717621
[TBL] [Abstract][Full Text] [Related]
17. High-affinity binding sites for bombesin on mouse colonic mucosal membranes.
Narayan S; Draviam E; Rajaraman S; Singh P
Mol Cell Biochem; 1991 Jul; 106(1):31-9. PubMed ID: 1656207
[TBL] [Abstract][Full Text] [Related]
18. Specific binding and growth effects of bombesin-related peptides on mouse colon cancer cells in vitro.
Narayan S; Guo YS; Townsend CM; Singh P
Cancer Res; 1990 Nov; 50(21):6772-8. PubMed ID: 2208141
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of antagonists of bombesin/gastrin releasing peptide (GRP) and somatostatin analog (RC-160) on growth of HT-29 human colon cancers in nude mice.
Radulovic S; Schally AV; Reile H; Halmos G; Szepeshazi K; Groot K; Milovanovic S; Miller G; Yano T
Acta Oncol; 1994; 33(6):693-701. PubMed ID: 7946450
[TBL] [Abstract][Full Text] [Related]
20. Receptors for GRP/bombesin-like peptides in the rat forebrain.
Wolf SS; Moody TW
Peptides; 1985; 6 Suppl 1():111-4. PubMed ID: 2995940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
